Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review

被引:12
|
作者
Christou, Andri [1 ]
Papastavrou, Evridiki [1 ]
Merkouris, Anastasios [1 ]
Frangos, Savvas [2 ]
Tamana, Panayiota [1 ]
Charalambous, Andreas [1 ,3 ]
机构
[1] Cyprus Univ Technol, Sch Hlth Sci, Dept Nursing, CY-3036 Limassol, Cyprus
[2] Bank Cyprus Oncol Ctr, Dept Nucl Med, Thyroid Canc Unit, CY-2006 Nicosia, Cyprus
[3] Univ Turku, Turku 20014, Finland
关键词
RADIOACTIVE IODINE; CANCER-PATIENTS; VITAMIN-E; QUALITY; PILOCARPINE; COMPLICATIONS; STIMULATION; AMIFOSTINE; MANAGEMENT; TRIALS;
D O I
10.1155/2016/6795076
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Purpose. To systematically review clinical studies examining the effectiveness of nonpharmacological methods to prevent/minimize salivary gland damage due to radioiodine treatment of differentiated thyroid carcinoma (DTC). Methods. Reports on relevant trials were identified by searching the PubMed, CINHAL, Cochrane, and Scopus electronic databases covering the period 01/2000-10/2015. Inclusion/exclusion criteria were prespecified. Search yielded eight studies that were reviewed by four of the present authors. Results. Nonpharmacological methods used in trials may reduce salivary gland damage induced by radioiodine. Sialogogues such as lemon candy, vitamin E, lemon juice, and lemon slice reduced such damage significantly (p < 0.0001, p < 0.05, p < 0.10, and p < 0.05, resp.). Parotid gland massage also reduced the salivary damage significantly (p < 0.001). Additionally, vitamin C had some limited effect (p = 0.37), whereas no effect was present in the case of chewing gum(p = 0.99). Conclusion. The review showed that, among nonpharmacological interventions, sialogogues and parotid gland massage had the greatest impact on reducing salivary damage induced by radioiodine therapy of DTC. However, the studies retrieved were limited in number, sample size, strength of evidence, and generalizability. More randomized controlled trials of these methods with multicenter scope and larger sample sizes will provide more systematic and reliable results allowing more definitive conclusions.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Does the Use of Amifostine for Salivary Gland Protection Reduce the Rate of Thyroid Remnant Ablation in Patients with Differentiated Thyroid Cancer Receiving Radioiodine Therapy?
    Haindl, W.
    Ting, A. C. C.
    Rossleigh, M. A.
    Som, S. S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S122 - S122
  • [42] Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis
    Luo, Yi
    Jiang, Hongyi
    Xu, Weibo
    Wang, Xiao
    Ma, Ben
    Liao, Tian
    Wang, Yu
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] The effect of salivary gland massage to prevent salivary gland dysfunction after high dose radioactive iodine therapy for differentiated thyroid cancer
    Son, Seung Hyun
    Ahn, Byoeng-Cheol
    Lee, Chang-Hee
    Jung, Ji-Hoon
    Jeong, Ju Hye
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [44] Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib
    Kawalec, Pawel
    Malinowska-Lipien, Iwona
    Brzostek, Tomasz
    Kozka, Maria
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1303 - 1309
  • [45] Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review
    Nai-Wei Sheu
    He-Jiun Jiang
    Che-Wei Wu
    Feng-Yu Chiang
    Hsin-Ying Clair Chiou
    Pi-Jung Hsiao
    [J]. World Journal of Surgical Oncology, 17
  • [46] Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review
    Sheu, Alai-Wei
    Jiang, He-Jiun
    Wu, Che-Wei
    Chiang, Feng-Yu
    Chiou, Hsin-Ying Clair
    Hsiao, Pi-Jung
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [47] Percutaneous Osteoplasty Combined With Radioiodine Therapy as a Treatment for Bone Metastasis Developing After Differentiated Thyroid Carcinoma
    Song, Hong-Jun
    Wu, Chun-Gen
    Xue, Yan-Li
    Xu, Yan-Hong
    Qiu, Zhong-Ling
    Luo, Quan-Yong
    [J]. CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : E129 - E133
  • [48] Physical and Biological DNA Dosimetry after Radioiodine Therapy of Patients with Differentiated Thyroid Carcinoma: First Results
    Lassmann, M.
    Haenscheid, H.
    Lorenz, R.
    Nerlich, K.
    Verburg, E.
    Meineke, V.
    Reiners, C.
    Scherthan, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S196 - S196
  • [49] Patient outcome after 1,1GBq radioiodine ablative therapy in differentiated thyroid carcinoma
    Carrilho Vaz, S.
    Sousa, R.
    Ferreira, T. C.
    Silva, A.
    Ratao, P.
    Daniel, A.
    Salgado, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S538 - S538
  • [50] 131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma (DTC)
    Nuvoli, S.
    Marongiu, A.
    Gelo, I.
    Mele, L.
    Rondini, M.
    Stazza, M. L.
    Madeddu, G.
    Spanu, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S698 - S699